ID   AURKB_HUMAN             Reviewed;         344 AA.
AC   Q96GD4; B4DNM4; C7G533; C7G534; C7G535; D3DTR4; J9JID1; O14630;
AC   O60446; O95083; Q96DV5; Q9UQ46;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   15-MAR-2017, entry version 187.
DE   RecName: Full=Aurora kinase B;
DE            EC=2.7.11.1;
DE   AltName: Full=Aurora 1;
DE   AltName: Full=Aurora- and IPL1-like midbody-associated protein 1;
DE            Short=AIM-1;
DE   AltName: Full=Aurora/IPL1-related kinase 2;
DE            Short=ARK-2;
DE            Short=Aurora-related kinase 2;
DE   AltName: Full=STK-1;
DE   AltName: Full=Serine/threonine-protein kinase 12;
DE   AltName: Full=Serine/threonine-protein kinase 5;
DE   AltName: Full=Serine/threonine-protein kinase aurora-B;
GN   Name=AURKB; Synonyms=AIK2, AIM1, AIRK2, ARK2, STK1, STK12, STK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-298.
RX   PubMed=9514916; DOI=10.1006/bbrc.1998.8250;
RA   Shindo M., Nakano H., Kuroyanagi H., Shirasawa T., Mihara M.,
RA   Gilbert D.J., Jenkins N.A., Copeland N.G., Yagita H., Okumura K.;
RT   "cDNA cloning, expression, subcellular localization, and chromosomal
RT   assignment of mammalian aurora homologues, aurora-related kinase (ARK)
RT   1 and 2.";
RL   Biochem. Biophys. Res. Commun. 244:285-292(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT THR-298.
RX   PubMed=9809983;
RA   Tatsuka M., Katayama H., Ota T., Tanaka T., Odashima S., Suzuki F.,
RA   Terada Y.;
RT   "Multinuclearity and increased ploidy caused by overexpression of the
RT   aurora- and Ipl1-like midbody-associated protein mitotic kinase in
RT   human cancer cells.";
RL   Cancer Res. 58:4811-4816(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT THR-298.
RC   TISSUE=Liver, and Spleen;
RX   PubMed=9858806;
RA   Kimura M., Matsuda Y., Yoshioka T., Sumi N., Okano Y.;
RT   "Identification and characterization of STK12/Aik2: a human gene
RT   related to aurora of Drosophila and yeast IPL1.";
RL   Cytogenet. Cell Genet. 82:147-152(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-298.
RX   PubMed=11471245;
RA   Prigent C., Gill R., Trower M., Sanseau P.;
RT   "In silico cloning of a new protein kinase, Aik2, related to
RT   Drosophila aurora using the new tool: EST Blast.";
RL   In Silico Biol. 1:123-128(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-298.
RA   Zhang Q., Yu L., Bi A.;
RT   "Cloning of a novel human gene homologous to mouse STK-1.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=19134008; DOI=10.1111/j.1349-7006.2008.01068.x;
RA   Yasen M., Mizushima H., Mogushi K., Obulhasim G., Miyaguchi K.,
RA   Inoue K., Nakahara I., Ohta T., Aihara A., Tanaka S., Arii S.,
RA   Tanaka H.;
RT   "Expression of Aurora B and alternative variant forms in
RT   hepatocellular carcinoma and adjacent tissue.";
RL   Cancer Sci. 100:472-480(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-298.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND VARIANT
RP   THR-298.
RC   TISSUE=Lung, Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   IDENTIFICATION IN THE CPC COMPLEX, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=11516652; DOI=10.1016/S0960-9822(01)00238-X;
RA   Wheatley S.P., Carvalho A., Vagnarelli P., Earnshaw W.C.;
RT   "INCENP is required for proper targeting of Survivin to the
RT   centromeres and the anaphase spindle during mitosis.";
RL   Curr. Biol. 11:886-890(2001).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11756469; DOI=10.1083/jcb.200108125;
RA   Zeitlin S.G., Shelby R.D., Sullivan K.F.;
RT   "CENP-A is phosphorylated by Aurora B kinase and plays an unexpected
RT   role in completion of cytokinesis.";
RL   J. Cell Biol. 155:1147-1157(2001).
RN   [14]
RP   REVIEW.
RX   PubMed=11413462; DOI=10.1038/35048096;
RA   Nigg E.A.;
RT   "Mitotic kinases as regulators of cell division and its checkpoints.";
RL   Nat. Rev. Mol. Cell Biol. 2:21-32(2001).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11856369; DOI=10.1046/j.1356-9597.2001.00498.x;
RA   Goto H., Yasui Y., Nigg E.A., Inagaki M.;
RT   "Aurora-B phosphorylates Histone H3 at serine28 with regard to the
RT   mitotic chromosome condensation.";
RL   Genes Cells 7:11-17(2002).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11784863; DOI=10.1128/MCB.22.3.874-885.2002;
RA   Crosio C., Fimia G.M., Loury R., Kimura M., Okano Y., Zhou H., Sen S.,
RA   Allis C.D., Sassone-Corsi P.;
RT   "Mitotic phosphorylation of histone H3: spatio-temporal regulation by
RT   mammalian Aurora kinases.";
RL   Mol. Cell. Biol. 22:874-885(2002).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH RACGAP1.
RX   PubMed=12689593; DOI=10.1016/S1534-5807(03)00089-3;
RA   Minoshima Y., Kawashima T., Hirose K., Tonozuka Y., Kawajiri A.,
RA   Bao Y.C., Deng X., Tatsuka M., Narumiya S., May W.S. Jr., Nosaka T.,
RA   Semba K., Inoue T., Satoh T., Inagaki M., Kitamura T.;
RT   "Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during
RT   cytokinesis.";
RL   Dev. Cell 4:549-560(2003).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12458200; DOI=10.1074/jbc.M210892200;
RA   Goto H., Yasui Y., Kawajiri A., Nigg E.A., Terada Y., Tatsuka M.,
RA   Nagata K., Inagaki M.;
RT   "Aurora-B regulates the cleavage furrow-specific vimentin
RT   phosphorylation in the cytokinetic process.";
RL   J. Biol. Chem. 278:8526-8530(2003).
RN   [19]
RP   FUNCTION, AND MUTAGENESIS OF LYS-106.
RX   PubMed=12686604; DOI=10.1091/mbc.E02-09-0612;
RA   Kawajiri A., Yasui Y., Goto H., Tatsuka M., Takahashi M., Nagata K.,
RA   Inagaki M.;
RT   "Functional significance of the specific sites phosphorylated in
RT   desmin at cleavage furrow: Aurora-B may phosphorylate and regulate
RT   type III intermediate filaments during cytokinesis coordinatedly with
RT   Rho-kinase.";
RL   Mol. Biol. Cell 14:1489-1500(2003).
RN   [20]
RP   IDENTIFICATION IN THE CPC COMPLEX, FUNCTION OF THE CPC COMPLEX,
RP   INDUCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND MUTAGENESIS OF
RP   LYS-106.
RX   PubMed=12925766; DOI=10.1091/mbc.E02-11-0769;
RA   Honda R., Korner R., Nigg E.A.;
RT   "Exploring the functional interactions between Aurora B, INCENP, and
RT   survivin in mitosis.";
RL   Mol. Biol. Cell 14:3325-3341(2003).
RN   [21]
RP   INTERACTION WITH PSMA3.
RX   PubMed=14674694; DOI=10.1023/A:1027317014159;
RA   Shu F., Guo S., Dang Y., Qi M., Zhou G., Guo Z., Zhang Y., Wu C.,
RA   Zhao S., Yu L.;
RT   "Human Aurora-B binds to a proteasome alpha-subunit HC8 and undergoes
RT   degradation in a proteasome-dependent manner.";
RL   Mol. Cell. Biochem. 254:157-162(2003).
RN   [22]
RP   FUNCTION.
RX   PubMed=14610074; DOI=10.1074/jbc.M311299200;
RA   Wheatley S.P., Henzing A.J., Dodson H., Khaled W., Earnshaw W.C.;
RT   "Aurora-B phosphorylation in vitro identifies a residue of survivin
RT   that is essential for its localization and binding to inner centromere
RT   protein (INCENP) in vivo.";
RL   J. Biol. Chem. 279:5655-5660(2004).
RN   [23]
RP   PHOSPHORYLATION AT THR-232, FUNCTION, INTERACTION WITH INCENP, ENZYME
RP   REGULATION, AND MUTAGENESIS OF LYS-106.
RX   PubMed=14722118; DOI=10.1074/jbc.M311128200;
RA   Yasui Y., Urano T., Kawajiri A., Nagata K., Tatsuka M., Saya H.,
RA   Furukawa K., Takahashi T., Izawa I., Inagaki M.;
RT   "Autophosphorylation of a newly identified site of Aurora-B is
RT   indispensable for cytokinesis.";
RL   J. Biol. Chem. 279:12997-13003(2004).
RN   [24]
RP   FUNCTION.
RX   PubMed=15020684; DOI=10.1242/jcs.01006;
RA   Johnson V.L., Scott M.I., Holt S.V., Hussein D., Taylor S.S.;
RT   "Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-
RT   F and Mad2, and chromosome congression.";
RL   J. Cell Sci. 117:1577-1589(2004).
RN   [25]
RP   INTERACTION WITH CDCA8, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=15249581; DOI=10.1083/jcb.200404001;
RA   Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F.,
RA   Honda R., Nigg E.A., Gerloff D.L., Earnshaw W.C.;
RT   "Borealin: a novel chromosomal passenger required for stability of the
RT   bipolar mitotic spindle.";
RL   J. Cell Biol. 166:179-191(2004).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH CDCA1 AND NDC80.
RX   PubMed=14602875; DOI=10.1074/mcp.M300072-MCP200;
RA   Tien A.-C., Lin M.-H., Su L.-J., Hong Y.-R., Cheng T.-S., Lee Y.-C.G.,
RA   Lin W.-J., Still I.H., Huang C.-Y.F.;
RT   "Identification of the substrates and interaction proteins of aurora
RT   kinases from a protein-protein interaction model.";
RL   Mol. Cell. Proteomics 3:93-104(2004).
RN   [27]
RP   INTERACTION WITH TACC1.
RX   PubMed=15064709; DOI=10.1038/sj.onc.1207593;
RA   Delaval B., Ferrand A., Conte N., Larroque C., Hernandez-Verdun D.,
RA   Prigent C., Birnbaum D.;
RT   "Aurora B -TACC1 protein complex in cytokinesis.";
RL   Oncogene 23:4516-4522(2004).
RN   [28]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SEPT1, AND MUTAGENESIS OF
RP   LYS-106.
RX   PubMed=16179162; DOI=10.1016/j.bbrc.2005.06.212;
RA   Qi M., Yu W., Liu S., Jia H., Tang L., Shen M., Yan X., Saiyin H.,
RA   Lang Q., Wan B., Zhao S., Yu L.;
RT   "Septin1, a new interaction partner for human serine/threonine kinase
RT   aurora-B.";
RL   Biochem. Biophys. Res. Commun. 336:994-1000(2005).
RN   [29]
RP   FUNCTION.
RX   PubMed=16103226; DOI=10.1083/jcb.200501097;
RA   Yuce O., Piekny A., Glotzer M.;
RT   "An ECT2-centralspindlin complex regulates the localization and
RT   function of RhoA.";
RL   J. Cell Biol. 170:571-582(2005).
RN   [30]
RP   INTERACTION WITH EVI5.
RX   PubMed=16764853; DOI=10.1016/j.yexcr.2006.03.032;
RA   Faitar S.L., Sossey-Alaoui K., Ranalli T.A., Cowell J.K.;
RT   "EVI5 protein associates with the INCENP-aurora B kinase-survivin
RT   chromosomal passenger complex and is involved in the completion of
RT   cytokinesis.";
RL   Exp. Cell Res. 312:2325-2335(2006).
RN   [31]
RP   FUNCTION.
RX   PubMed=17617734; DOI=10.4161/cc.6.13.4442;
RA   Pouwels J., Kukkonen A.M., Lan W., Daum J.R., Gorbsky G.J.,
RA   Stukenberg T., Kallio M.J.;
RT   "Shugoshin 1 plays a central role in kinetochore assembly and is
RT   required for kinetochore targeting of Plk1.";
RL   Cell Cycle 6:1579-1585(2007).
RN   [32]
RP   UBIQUITINATION.
RX   PubMed=17543862; DOI=10.1016/j.devcel.2007.03.019;
RA   Sumara I., Quadroni M., Frei C., Olma M.H., Sumara G., Ricci R.,
RA   Peter M.;
RT   "A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes,
RT   regulating mitotic progression and completion of cytokinesis in human
RT   cells.";
RL   Dev. Cell 12:887-900(2007).
RN   [33]
RP   INTERACTION WITH SIRT2, AND SUBCELLULAR LOCATION.
RX   PubMed=17726514; DOI=10.1371/journal.pone.0000784;
RA   North B.J., Verdin E.;
RT   "Interphase nucleo-cytoplasmic shuttling and localization of SIRT2
RT   during mitosis.";
RL   PLoS ONE 2:E784-E784(2007).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [35]
RP   INTERACTION WITH BIRC5.
RX   PubMed=18591255; DOI=10.1128/MCB.02039-07;
RA   Xia F., Canovas P.M., Guadagno T.M., Altieri D.C.;
RT   "A survivin-ran complex regulates spindle formation in tumor cells.";
RL   Mol. Cell. Biol. 28:5299-5311(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [37]
RP   UBIQUITINATION.
RX   PubMed=19995937; DOI=10.1083/jcb.200906117;
RA   Maerki S., Olma M.H., Staubli T., Steigemann P., Gerlich D.W.,
RA   Quadroni M., Sumara I., Peter M.;
RT   "The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone
RT   microtubules in anaphase and is required for cytokinesis.";
RL   J. Cell Biol. 187:791-800(2009).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [39]
RP   INTERACTION WITH SPDYC, AND SUBCELLULAR LOCATION.
RX   PubMed=20605920; DOI=10.1242/jcs.059964;
RA   Mouron S., de Carcer G., Seco E., Fernandez-Miranda G., Malumbres M.,
RA   Nebreda A.R.;
RT   "RINGO C is required to sustain the spindle-assembly checkpoint.";
RL   J. Cell Sci. 123:2586-2595(2010).
RN   [40]
RP   INTERACTION WITH INCENP.
RX   PubMed=20562864; DOI=10.1038/ncb2075;
RA   Nozawa R.S., Nagao K., Masuda H.T., Iwasaki O., Hirota T., Nozaki N.,
RA   Kimura H., Obuse C.;
RT   "Human POGZ modulates dissociation of HP1alpha from mitotic chromosome
RT   arms through Aurora B activation.";
RL   Nat. Cell Biol. 12:719-727(2010).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62 AND THR-64, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [42]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20929775; DOI=10.1126/science.1194498;
RA   Yamagishi Y., Honda T., Tanno Y., Watanabe Y.;
RT   "Two histone marks establish the inner centromere and chromosome bi-
RT   orientation.";
RL   Science 330:239-243(2010).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [44]
RP   FUNCTION IN PHOSPHORYLATION OF GSG2.
RX   PubMed=21658950; DOI=10.1016/j.cub.2011.05.016;
RA   Wang F., Ulyanova N.P., van der Waal M.S., Patnaik D., Lens S.M.,
RA   Higgins J.M.;
RT   "A positive feedback loop involving Haspin and Aurora B promotes CPC
RT   accumulation at centromeres in mitosis.";
RL   Curr. Biol. 21:1061-1069(2011).
RN   [45]
RP   FUNCTION IN PHOSPHORYLATION OF TP53, INTERACTION WITH NOC2L AND TP53,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=20959462; DOI=10.1074/jbc.M110.174755;
RA   Wu L., Ma C.A., Zhao Y., Jain A.;
RT   "Aurora B interacts with NIR-p53, leading to p53 phosphorylation in
RT   its DNA-binding domain and subsequent functional suppression.";
RL   J. Biol. Chem. 286:2236-2244(2011).
RN   [46]
RP   INTERACTION WITH JTB.
RX   PubMed=21225229; DOI=10.3892/ijo.2011.900;
RA   Platica M., Ionescu A., Ivan E., Holland J.F., Mandeli J., Platica O.;
RT   "PAR, a protein involved in the cell cycle, is functionally related to
RT   chromosomal passenger proteins.";
RL   Int. J. Oncol. 38:777-785(2011).
RN   [47]
RP   INTERACTION WITH TTC28, AND SUBCELLULAR LOCATION.
RX   PubMed=23036704; DOI=10.1016/j.gene.2012.09.061;
RA   Izumiyama T., Minoshima S., Yoshida T., Shimizu N.;
RT   "A novel big protein TPRBK possessing 25 units of TPR motif is
RT   essential for the progress of mitosis and cytokinesis.";
RL   Gene 511:202-217(2012).
RN   [48]
RP   FUNCTION, AND INTERACTION WITH CHMP4C.
RX   PubMed=22422861; DOI=10.1126/science.1217180;
RA   Carlton J.G., Caballe A., Agromayor M., Kloc M., Martin-Serrano J.;
RT   "ESCRT-III governs the Aurora B-mediated abscission checkpoint through
RT   CHMP4C.";
RL   Science 336:220-225(2012).
RN   [49]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [50]
RP   FUNCTION.
RX   PubMed=24814515; DOI=10.1038/ncb2959;
RA   Thoresen S.B., Campsteijn C., Vietri M., Schink K.O., Liestoel K.,
RA   Andersen J.S., Raiborg C., Stenmark H.;
RT   "ANCHR mediates Aurora-B-dependent abscission checkpoint control
RT   through retention of VPS4.";
RL   Nat. Cell Biol. 16:550-560(2014).
RN   [51]
RP   SUBUNIT.
RX   PubMed=27332895; DOI=10.1371/journal.pone.0157305;
RA   Sasai K., Katayama H., Hawke D.H., Sen S.;
RT   "Aurora-C interactions with survivin and INCENP reveal shared and
RT   distinct features compared with Aurora-B chromosome passenger protein
RT   complex.";
RL   PLoS ONE 11:E0157305-E0157305(2016).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 55-344 IN COMPLEX WITH
RP   INCENP.
RX   PubMed=22920039; DOI=10.1021/jm3008954;
RA   Elkins J.M., Santaguida S., Musacchio A., Knapp S.;
RT   "Crystal structure of human aurora B in complex with INCENP and VX-
RT   680.";
RL   J. Med. Chem. 55:7841-7848(2012).
RN   [53]
RP   VARIANT THR-298.
RX   PubMed=16762494; DOI=10.1016/j.canlet.2006.05.002;
RA   Tchatchou S., Wirtenberger M., Hemminki K., Sutter C., Meindl A.,
RA   Wappenschmidt B., Kiechle M., Bugert P., Schmutzler R.K.,
RA   Bartram C.R., Burwinkel B.;
RT   "Aurora kinases A and B and familial breast cancer risk.";
RL   Cancer Lett. 247:266-272(2007).
RN   [54]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-52 AND MET-179.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase component of the
CC       chromosomal passenger complex (CPC), a complex that acts as a key
CC       regulator of mitosis. The CPC complex has essential functions at
CC       the centromere in ensuring correct chromosome alignment and
CC       segregation and is required for chromatin-induced microtubule
CC       stabilization and spindle assembly. Involved in the bipolar
CC       attachment of spindle microtubules to kinetochores and is a key
CC       regulator for the onset of cytokinesis during mitosis. Required
CC       for central/midzone spindle assembly and cleavage furrow
CC       formation. Key component of the cytokinesis checkpoint, a process
CC       required to delay abscission to prevent both premature resolution
CC       of intercellular chromosome bridges and accumulation of DNA
CC       damage: phosphorylates CHMP4C, leading to retain abscission-
CC       competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until
CC       abscission checkpoint signaling is terminated at late cytokinesis
CC       (PubMed:22422861, PubMed:24814515). AURKB phosphorylates the CPC
CC       complex subunits BIRC5/survivin, CDCA8/borealin and INCENP.
CC       Phosphorylation of INCENP leads to increased AURKB activity. Other
CC       known AURKB substrates involved in centromeric functions and
CC       mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPT1,
CC       VIM/vimentin, GSG2/Haspin, and histone H3. A positive feedback
CC       loop involving GSG2 and AURKB contributes to localization of CPC
CC       to centromeres. Phosphorylation of VIM controls vimentin filament
CC       segregation in cytokinetic process, whereas histone H3 is
CC       phosphorylated at 'Ser-10' and 'Ser-28' during mitosis (H3S10ph
CC       and H3S28ph, respectively). A positive feedback between GSG2 and
CC       AURKB contributes to CPC localization. AURKB is also required for
CC       kinetochore localization of BUB1 and SGO1. Phosphorylation of
CC       p53/TP53 negatively regulates its transcriptional activity. Key
CC       regulator of active promoters in resting B- and T-lymphocytes:
CC       acts by mediating phosphorylation of H3S28ph at active promoters
CC       in resting B-cells, inhibiting RNF2/RING1B-mediated ubiquitination
CC       of histone H2A and enhancing binding and activity of the USP16
CC       deubiquitinase at transcribed genes. {ECO:0000269|PubMed:11516652,
CC       ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:11784863,
CC       ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12458200,
CC       ECO:0000269|PubMed:12686604, ECO:0000269|PubMed:12689593,
CC       ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14602875,
CC       ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:14722118,
CC       ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15249581,
CC       ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:17617734,
CC       ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:21658950,
CC       ECO:0000269|PubMed:22422861, ECO:0000269|PubMed:24814515}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activity is greatly increased when AURKB is
CC       within the CPC complex. In particular, AURKB-phosphorylated INCENP
CC       acts as an activator of AURKB. Positive feedback between GSG2 and
CC       AURKB contributes to CPC localization.
CC       {ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14722118,
CC       ECO:0000269|PubMed:15249581}.
CC   -!- SUBUNIT: Component of the chromosomal passenger complex (CPC)
CC       composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB
CC       or AURKC; predominantly independent AURKB- and AURKC-containing
CC       complexes exist. Associates with RACGAP1 during M phase. Interacts
CC       with CDCA1, EVI5, JTB, NDC80, PSMA3, SEPT1, SIRT2 and TACC1.
CC       Interacts with SPDYC; this interaction may be required for proper
CC       localization of active, Thr-232-phosphorylated AURKB form during
CC       prometaphase and metaphase. Interacts with p53/TP53. Interacts
CC       (via the middle kinase domain) with NOC2L (via the N- and C-
CC       terminus domains). Interacts with TTC28. Interacts with
CC       RNF2/RING1B. {ECO:0000269|PubMed:11516652,
CC       ECO:0000269|PubMed:12689593, ECO:0000269|PubMed:12925766,
CC       ECO:0000269|PubMed:14602875, ECO:0000269|PubMed:14674694,
CC       ECO:0000269|PubMed:14722118, ECO:0000269|PubMed:15064709,
CC       ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:16179162,
CC       ECO:0000269|PubMed:16764853, ECO:0000269|PubMed:17726514,
CC       ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:20562864,
CC       ECO:0000269|PubMed:20605920, ECO:0000269|PubMed:20959462,
CC       ECO:0000269|PubMed:21225229, ECO:0000269|PubMed:22422861,
CC       ECO:0000269|PubMed:23036704, ECO:0000269|PubMed:27332895}.
CC   -!- INTERACTION:
CC       O15392:BIRC5; NbExp=10; IntAct=EBI-624291, EBI-518823;
CC       O15392-1:BIRC5; NbExp=2; IntAct=EBI-624291, EBI-518838;
CC       O15392-2:BIRC5; NbExp=2; IntAct=EBI-624291, EBI-518842;
CC       Q16543:CDC37; NbExp=2; IntAct=EBI-624291, EBI-295634;
CC       Q86XJ1:GAS2L3; NbExp=4; IntAct=EBI-624291, EBI-9248152;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-624291, EBI-352572;
CC       Q9NQS7:INCENP; NbExp=13; IntAct=EBI-624291, EBI-307907;
CC       P06748:NPM1; NbExp=5; IntAct=EBI-624291, EBI-78579;
CC       Q8WYJ6:SEPT1; NbExp=6; IntAct=EBI-624291, EBI-693002;
CC       O75410-6:TACC1; NbExp=2; IntAct=EBI-624291, EBI-624278;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere.
CC       Cytoplasm, cytoskeleton, spindle. Midbody. Note=Localizes on
CC       chromosome arms and inner centromeres from prophase through
CC       metaphase and then transferring to the spindle midzone and midbody
CC       from anaphase through cytokinesis. Colocalized with gamma tubulin
CC       in the midbody. Proper localization of the active, Thr-232-
CC       phosphorylated form during metaphase may be dependent upon
CC       interaction with SPDYC. Colocalized with SIRT2 during cytokinesis
CC       with the midbody. Localization (and probably targeting of the CPC)
CC       to the inner centromere occurs predominantly in regions with
CC       overlapping mitosis-specific histone phosphorylations H3pT3 and
CC       H2ApT12. {ECO:0000269|PubMed:20929775}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q96GD4-1; Sequence=Displayed;
CC       Name=2; Synonyms=aurkb-sv1;
CC         IsoId=Q96GD4-2; Sequence=VSP_044385;
CC       Name=3; Synonyms=aurkb-sv2;
CC         IsoId=Q96GD4-3; Sequence=VSP_044384, VSP_044386, VSP_044387;
CC         Note=Not expressed in normal liver, high expression in
CC         metastatic liver.;
CC       Name=4;
CC         IsoId=Q96GD4-4; Sequence=VSP_047103;
CC       Name=5;
CC         IsoId=Q96GD4-5; Sequence=VSP_044384;
CC   -!- TISSUE SPECIFICITY: High level expression seen in the thymus. It
CC       is also expressed in the spleen, lung, testis, colon, placenta and
CC       fetal liver. Expressed during S and G2/M phase and expression is
CC       up-regulated in cancer cells during M phase.
CC       {ECO:0000269|PubMed:9809983, ECO:0000269|PubMed:9858806}.
CC   -!- INDUCTION: Expression is cell cycle-regulated, with a low in G1/S,
CC       an increase during G2 and M. Expression decreases again after M
CC       phase. {ECO:0000269|PubMed:12925766}.
CC   -!- PTM: The phosphorylation of Thr-232 requires the binding to INCENP
CC       and occurs by means of an autophosphorylation mechanism. Thr-232
CC       phosphorylation is indispensable for the AURKB kinase activity.
CC       {ECO:0000269|PubMed:14722118}.
CC   -!- PTM: Ubiquitinated by different BCR (BTB-CUL3-RBX1) E3 ubiquitin
CC       ligase complexes. Ubiquitinated by the BCR(KLHL9-KLHL13) E3
CC       ubiquitin ligase complex, ubiquitination leads to removal from
CC       mitotic chromosomes and is required for cytokinesis. During
CC       anaphase, the BCR(KLHL21) E3 ubiquitin ligase complex recruits the
CC       CPC complex from chromosomes to the spindle midzone and mediates
CC       the ubiquitination of AURKB. Ubiquitination of AURKB by
CC       BCR(KLHL21) E3 ubiquitin ligase complex may not lead to its
CC       degradation by the proteasome. {ECO:0000269|PubMed:17543862,
CC       ECO:0000269|PubMed:19995937}.
CC   -!- DISEASE: Note=Disruptive regulation of expression is a possible
CC       mechanism of the perturbation of chromosomal integrity in cancer
CC       cells through its dominant-negative effect on cytokinesis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. Aurora subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13300.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008552; AAC12709.1; -; mRNA.
DR   EMBL; AB011450; BAA32136.1; -; mRNA.
DR   EMBL; AB011446; BAA82709.1; -; mRNA.
DR   EMBL; AF004022; AAB65786.1; -; mRNA.
DR   EMBL; AF015254; AAC98891.1; -; mRNA.
DR   EMBL; AB519677; BAI23190.1; -; mRNA.
DR   EMBL; AB519678; BAI23191.1; -; mRNA.
DR   EMBL; AB519679; BAI23192.1; -; mRNA.
DR   EMBL; BT019534; AAV38341.1; -; mRNA.
DR   EMBL; AK297976; BAG60286.1; -; mRNA.
DR   EMBL; AC135178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90075.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90077.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90078.1; -; Genomic_DNA.
DR   EMBL; BC000442; AAH00442.3; -; mRNA.
DR   EMBL; BC009751; AAH09751.1; -; mRNA.
DR   EMBL; BC013300; AAH13300.2; ALT_INIT; mRNA.
DR   EMBL; BC080581; AAH80581.1; -; mRNA.
DR   CCDS; CCDS11134.1; -. [Q96GD4-1]
DR   CCDS; CCDS58514.1; -. [Q96GD4-4]
DR   CCDS; CCDS67162.1; -. [Q96GD4-5]
DR   CCDS; CCDS82065.1; -. [Q96GD4-2]
DR   RefSeq; NP_001243763.1; NM_001256834.2. [Q96GD4-4]
DR   RefSeq; NP_001271455.1; NM_001284526.1. [Q96GD4-5]
DR   RefSeq; NP_001300879.1; NM_001313950.1. [Q96GD4-1]
DR   RefSeq; NP_001300880.1; NM_001313951.1. [Q96GD4-4]
DR   RefSeq; NP_001300881.1; NM_001313952.1.
DR   RefSeq; NP_001300882.1; NM_001313953.1. [Q96GD4-2]
DR   RefSeq; NP_001300883.1; NM_001313954.1.
DR   RefSeq; NP_001300884.1; NM_001313955.1.
DR   RefSeq; NP_004208.2; NM_004217.3. [Q96GD4-1]
DR   RefSeq; XP_011522372.1; XM_011524070.2. [Q96GD4-2]
DR   RefSeq; XP_011522374.1; XM_011524072.2. [Q96GD4-4]
DR   RefSeq; XP_016880796.1; XM_017025307.1. [Q96GD4-4]
DR   UniGene; Hs.442658; -.
DR   PDB; 4AF3; X-ray; 2.75 A; A=55-344.
DR   PDBsum; 4AF3; -.
DR   ProteinModelPortal; Q96GD4; -.
DR   SMR; Q96GD4; -.
DR   BioGrid; 114646; 157.
DR   DIP; DIP-34530N; -.
DR   IntAct; Q96GD4; 47.
DR   MINT; MINT-1413997; -.
DR   STRING; 9606.ENSP00000463999; -.
DR   BindingDB; Q96GD4; -.
DR   ChEMBL; CHEMBL2185; -.
DR   DrugBank; DB05169; AT9283.
DR   DrugBank; DB04703; HESPERIDIN.
DR   GuidetoPHARMACOLOGY; 1937; -.
DR   iPTMnet; Q96GD4; -.
DR   PhosphoSitePlus; Q96GD4; -.
DR   SwissPalm; Q96GD4; -.
DR   BioMuta; AURKB; -.
DR   DMDM; 317373473; -.
DR   EPD; Q96GD4; -.
DR   MaxQB; Q96GD4; -.
DR   PaxDb; Q96GD4; -.
DR   PeptideAtlas; Q96GD4; -.
DR   PRIDE; Q96GD4; -.
DR   DNASU; 9212; -.
DR   Ensembl; ENST00000316199; ENSP00000313950; ENSG00000178999. [Q96GD4-5]
DR   Ensembl; ENST00000534871; ENSP00000443869; ENSG00000178999. [Q96GD4-4]
DR   Ensembl; ENST00000578549; ENSP00000462207; ENSG00000178999. [Q96GD4-2]
DR   Ensembl; ENST00000585124; ENSP00000463999; ENSG00000178999. [Q96GD4-1]
DR   GeneID; 9212; -.
DR   KEGG; hsa:9212; -.
DR   UCSC; uc002gkm.5; human. [Q96GD4-1]
DR   CTD; 9212; -.
DR   DisGeNET; 9212; -.
DR   GeneCards; AURKB; -.
DR   H-InvDB; HIX0019005; -.
DR   HGNC; HGNC:11390; AURKB.
DR   HPA; CAB005862; -.
DR   HPA; HPA037708; -.
DR   MIM; 604970; gene.
DR   neXtProt; NX_Q96GD4; -.
DR   OpenTargets; ENSG00000178999; -.
DR   PharmGKB; PA36199; -.
DR   eggNOG; KOG0580; Eukaryota.
DR   eggNOG; ENOG410XNRB; LUCA.
DR   GeneTree; ENSGT00870000136439; -.
DR   HOVERGEN; HBG108519; -.
DR   InParanoid; Q96GD4; -.
DR   KO; K11479; -.
DR   OMA; TPNILTR; -.
DR   OrthoDB; EOG091G0EU2; -.
DR   PhylomeDB; Q96GD4; -.
DR   TreeFam; TF351439; -.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SignaLink; Q96GD4; -.
DR   SIGNOR; Q96GD4; -.
DR   GeneWiki; Aurora_B_kinase; -.
DR   GenomeRNAi; 9212; -.
DR   PRO; PR:Q96GD4; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000178999; -.
DR   CleanEx; HS_AIM1; -.
DR   CleanEx; HS_AURKB; -.
DR   ExpressionAtlas; Q96GD4; baseline and differential.
DR   Genevisible; Q96GD4; HS.
DR   GO; GO:0010369; C:chromocenter; IEA:Ensembl.
DR   GO; GO:0032133; C:chromosome passenger complex; IPI:UniProtKB.
DR   GO; GO:0000779; C:condensed chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0000780; C:condensed nuclear chromosome, centromeric region; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:1990023; C:mitotic spindle midzone; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; TAS:UniProtKB.
DR   GO; GO:0005876; C:spindle microtubule; IBA:GO_Central.
DR   GO; GO:0051233; C:spindle midzone; IBA:GO_Central.
DR   GO; GO:0031616; C:spindle pole centrosome; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035174; F:histone serine kinase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:FlyBase.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB.
DR   GO; GO:0009838; P:abscission; ISS:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; TAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0036089; P:cleavage furrow formation; IDA:UniProtKB.
DR   GO; GO:0043988; P:histone H3-S28 phosphorylation; ISS:UniProtKB.
DR   GO; GO:0016570; P:histone modification; TAS:UniProtKB.
DR   GO; GO:0051256; P:mitotic spindle midzone assembly; IMP:UniProtKB.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032466; P:negative regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IMP:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; TAS:UniProtKB.
DR   GO; GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0051983; P:regulation of chromosome segregation; TAS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   GO; GO:0031577; P:spindle checkpoint; IEA:InterPro.
DR   GO; GO:0007051; P:spindle organization; IMP:UniProtKB.
DR   InterPro; IPR030616; Aur.
DR   InterPro; IPR028772; AURKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24350; PTHR24350; 1.
DR   PANTHER; PTHR24350:SF16; PTHR24350:SF16; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Centromere; Chromosome; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Kinase; Magnesium; Metal-binding; Mitosis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    344       Aurora kinase B.
FT                                /FTId=PRO_0000085656.
FT   DOMAIN       77    327       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      83     91       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    200    200       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     106    106       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      35     35       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      64     64       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     232    232       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:14722118}.
FT   VAR_SEQ       1     41       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047103.
FT   VAR_SEQ      69     69       T -> TR (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19134008}.
FT                                /FTId=VSP_044384.
FT   VAR_SEQ      86    134       GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREI
FT                                EIQAHLHH -> ALLCLWPEASSVSSPSH (in isoform
FT                                2). {ECO:0000303|PubMed:19134008}.
FT                                /FTId=VSP_044385.
FT   VAR_SEQ     133    141       HHPNILRLY -> QSWRSWQML (in isoform 3).
FT                                {ECO:0000303|PubMed:19134008}.
FT                                /FTId=VSP_044386.
FT   VAR_SEQ     142    344       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:19134008}.
FT                                /FTId=VSP_044387.
FT   VARIANT      52     52       A -> V (in dbSNP:rs55878091).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040383.
FT   VARIANT     100    100       H -> Q (in dbSNP:rs3027254).
FT                                /FTId=VAR_027970.
FT   VARIANT     179    179       T -> M (in dbSNP:rs55871613).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040384.
FT   VARIANT     298    298       M -> T (in dbSNP:rs1059476).
FT                                {ECO:0000269|PubMed:11471245,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16762494,
FT                                ECO:0000269|PubMed:9514916,
FT                                ECO:0000269|PubMed:9809983,
FT                                ECO:0000269|PubMed:9858806,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_027971.
FT   MUTAGEN     106    106       K->R: Leads to loss of kinase activity
FT                                and severely impairs mitotic progression.
FT                                {ECO:0000269|PubMed:12686604,
FT                                ECO:0000269|PubMed:12925766,
FT                                ECO:0000269|PubMed:14722118,
FT                                ECO:0000269|PubMed:16179162}.
FT   CONFLICT     14     15       RQ -> DK (in Ref. 5; AAC98891).
FT                                {ECO:0000305}.
FT   CONFLICT    161    161       E -> M (in Ref. 4; AAB65786 and 5;
FT                                AAC98891). {ECO:0000305}.
FT   CONFLICT    167    169       QKS -> HKT (in Ref. 4; AAB65786).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       T -> TVRR (in Ref. 4; AAB65786).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       I -> VRAV (in Ref. 5; AAC98891).
FT                                {ECO:0000305}.
FT   CONFLICT    226    226       P -> T (in Ref. 3; BAA82709).
FT                                {ECO:0000305}.
FT   CONFLICT    249    250       MH -> ID (in Ref. 3; BAA82709).
FT                                {ECO:0000305}.
FT   CONFLICT    271    271       Missing (in Ref. 3; BAA82709).
FT                                {ECO:0000305}.
FT   HELIX        74     76       {ECO:0000244|PDB:4AF3}.
FT   STRAND       77     82       {ECO:0000244|PDB:4AF3}.
FT   STRAND       89     96       {ECO:0000244|PDB:4AF3}.
FT   TURN         97     99       {ECO:0000244|PDB:4AF3}.
FT   STRAND      102    109       {ECO:0000244|PDB:4AF3}.
FT   HELIX       110    116       {ECO:0000244|PDB:4AF3}.
FT   HELIX       119    130       {ECO:0000244|PDB:4AF3}.
FT   STRAND      140    145       {ECO:0000244|PDB:4AF3}.
FT   STRAND      147    155       {ECO:0000244|PDB:4AF3}.
FT   HELIX       162    169       {ECO:0000244|PDB:4AF3}.
FT   HELIX       174    193       {ECO:0000244|PDB:4AF3}.
FT   HELIX       203    205       {ECO:0000244|PDB:4AF3}.
FT   STRAND      206    208       {ECO:0000244|PDB:4AF3}.
FT   STRAND      214    216       {ECO:0000244|PDB:4AF3}.
FT   HELIX       242    245       {ECO:0000244|PDB:4AF3}.
FT   HELIX       253    268       {ECO:0000244|PDB:4AF3}.
FT   HELIX       278    286       {ECO:0000244|PDB:4AF3}.
FT   HELIX       298    307       {ECO:0000244|PDB:4AF3}.
FT   HELIX       312    314       {ECO:0000244|PDB:4AF3}.
FT   HELIX       318    322       {ECO:0000244|PDB:4AF3}.
FT   HELIX       325    330       {ECO:0000244|PDB:4AF3}.
SQ   SEQUENCE   344 AA;  39311 MW;  A5ED13EF5A1FAFBF CRC64;
     MAQKENSYPW PYGRQTAPSG LSTLPQRVLR KEPVTPSALV LMSRSNVQPT AAPGQKVMEN
     SSGTPDILTR HFTIDDFEIG RPLGKGKFGN VYLAREKKSH FIVALKVLFK SQIEKEGVEH
     QLRREIEIQA HLHHPNILRL YNYFYDRRRI YLILEYAPRG ELYKELQKSC TFDEQRTATI
     MEELADALMY CHGKKVIHRD IKPENLLLGL KGELKIADFG WSVHAPSLRR KTMCGTLDYL
     PPEMIEGRMH NEKVDLWCIG VLCYELLVGN PPFESASHNE TYRRIVKVDL KFPASVPMGA
     QDLISKLLRH NPSERLPLAQ VSAHPWVRAN SRRVLPPSAL QSVA
//
